WinstonWınston
U.S. Physical Therapy logo

U.S. Physical Therapy

USPH
41
Medical - Care Facilities · Healthcare
Price
$73.56
-0.63 (-0.85%)
Market Cap
$1.12B
Winston Score
41
Winston is serious
Mixed quality — meaningful strengths and weaknesses.

Share count rising — dilution

+17.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 12.9M (2021) → 15.2M (2025)

U.S. Physical Therapy operates a network of outpatient physical and occupational therapy clinics across the United States. The company treats patients recovering from injuries, surgeries, and chronic conditions like back pain or sports injuries. It is one of the larger independent operators of physical therapy clinics in the country, with over 600 locations in dozens of states.

The company earns revenue primarily by billing insurance companies, Medicare, Medicaid, and patients directly for therapy sessions. Most clinics are staffed by licensed physical therapists, and the business model relies on high patient volume across its locations. Its competitive position comes partly from scale and its partnerships with physician groups and hospitals that refer patients to its clinics. The main risk the company faces is reimbursement pressure, since government and private insurers regularly adjust how much they pay per therapy visit, which directly squeezes profit margins.

Winston Score History

Politician Trades

2 trades / 12mo

0 Congressional buys and 2 sells on USPH in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+30.0% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-115.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

2.5%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~5 years

$28M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$28M cash & investments at current burn rate

Revenue accelerating

U.S. Physical Therapy grew revenue 30% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
14.5%
Thin — 14.5% gross margin
Operating Margin
7.5%
Modest — 7.5% operating margin
ROCE
2.1%
Weak — 2.1% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+9.1%
Steady sales growth (9.1% YoY)
EPS YoY
-77.1%
Earnings shrinking (-77.1% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
7096%
Turns 7096% of profit into real cash
FCF Margin
9.2%
Modest free cash flow (9.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.53
Conservative — low debt load (0.53)
Interest Cover
8.75x
Comfortably covers interest (8.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
147.1x
Expensive — P/E 147.1

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+121.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (147.1 → 25.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.52%
Moderate income — 2.52% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+2.2%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial